This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses may be missing. Find their university profile.
Research
Latest papers
A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma.
Cell reports. Medicine · 2026
CCR2- T peripheral helper cells as potential coordinators of local immune architecture in human cancer.
Discovery immunology · 2026 · senior author
CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer.
The Journal of clinical investigation · 2026
Latest funding
- $120,000
Remodeler le microenvironnement immunitaire du cancer ovarien à l'aide de virus oncolytiques
CIHR · 2025 · Supervisor
- $10,000
Colloque 'Signalisation Québec 2024'
CIHR · 2023 · Co-investigator
- $12,500
Building of a functional single cell proteomics resource for the study the DNA damage response
NSERC · 2022 · Principal investigator
13 publications.
A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma.
Wei S, Deng Y, Lee J, Lan H, Yang Z, Labrie M, Betts CB, Duan H, Tate B, Pucilowska J, Frederick D, Lawless AR, Sharova T, Yang Y, Hu W, Beasley GM, Schuchter LM, Wang X, Xu W, Yong G, Vandenberg MEG, Torigian DA, Sivagnanam S, Du K, Sugarman E, McGettigan S, Zheng C, Al-Rohil RN, Selim MA, Datto MB, López GY, Nair SK, Ashley DM, Xu X, Amaravadi RK, Karakousis GC, O'Rourke DM, Brem S, O'Malley BW, Demirkan G, Yu S, Lu Y, Camp T, Patterson JA, Wei Z, Corless C, Gabrilovich DI, Mou Y, Flaherty KT, Coussens LM, Boland G, Herlyn M, Mills G, Liu L, Zhang G
CCR2- T peripheral helper cells as potential coordinators of local immune architecture in human cancer.
Crespo Oliva CDC, Gerber Z, Jean D, Allard-Chamard H, Labrie M
CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer.
Napolitano F, Wang Y, Sudhan DR, Gonzalez-Ericsson PI, Formisano L, Unni N, Shakeel S, Zhu JZ, Ahuja K, Guo L, Chica-Parrado MR, Matsunaga Y, Luna P, Lin CA, Uemoto Y, Lee KM, Ma H, Evans NJ, Servetto A, Mendiratta S, Barnes SD, Bianco R, Fang YV, Xu L, Lee J, Wang T, Balko JM, Mills GB, Labrie M, Hanker AB, Arteaga CL
ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer.
Shi SN, Xu Q, Liao Z, Gong W, Cui Y, Liu J, Jiao X, Wu Y, Luo M, Zhang Y, Wang L, Wen Y, Pan W, Zhao X, Labrie M, Ding Z, Mills GB, Ma D, Zhao GN, Gao Q, Fang Y
Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with PARP and ATR inhibitors combination.
Gong W, Liao Z, Xiong F, Wang L, Shi S, Luo M, Zhang Y, Xu Q, Wang Y, Wu Y, Zhu L, Kuang D, Labrie M, Mills GB, Ma D, Liu D, Zhao GN, Gao Q, Fang Y
Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancer.
Zhao X, Lai H, Li G, Qin Y, Chen R, Labrie M, Stommel JM, Mills GB, Ma D, Gao Q, Fang Y
Current preclinical models of brain metastasis.
Drouin Z, Lévesque F, Mouzakitis K, Labrie M
T peripheral helper (Tph) cells, a marker of immune activation in cancer and autoimmune disorders.
Del Carmen Crespo Oliva C, Labrie M, Allard-Chamard H
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.
Dareng EO, Coetzee SG, Tyrer JP, Peng PC, Rosenow W, Chen S, Davis BD, Dezem FS, Seo JH, Nameki R, Reyes AL, Aben KKH, Anton-Culver H, Antonenkova NN, Aravantinos G, Bandera EV, Beane Freeman LE, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bernardini MQ, Bjorge L, Black A, Bogdanova NV, Bolton KL, Brenton JD, Budzilowska A, Butzow R, Cai H, Campbell I, Cannioto R, Chang-Claude J, Chanock SJ, Chen K, Chenevix-Trench G, AOCS Group, Chiew YE, Cook LS, DeFazio A, Dennis J, Doherty JA, Dörk T, du Bois A, Dürst M, Eccles DM, Ene G, Fasching PA, Flanagan JM, Fortner RT, Fostira F, Gentry-Maharaj A, Giles GG, Goodman MT, Gronwald J, Haiman CA, Håkansson N, Heitz F, Hildebrandt MAT, Høgdall E, Høgdall CK, Huang RY, Jensen A, Jones ME, Kang D, Karlan BY, Karnezis AN, Kelemen LE, Kennedy CJ, Khusnutdinova EK, Kiemeney LA, Kjaer SK, Kupryjanczyk J, Labrie M, Lambrechts D, Larson MC, Le ND, Lester J, Li L, Lubiński J, Lush M, Marks JR, Matsuo K, May T, McLaughlin JR, McNeish IA, Menon U, Missmer S, Modugno F, Moffitt M, Monteiro AN, Moysich KB, Narod SA, Nguyen-Dumont T, Odunsi K, Olsson H, Onland-Moret NC, Park SK, Pejovic T, Permuth JB, Piskorz A, Prokofyeva D, Riggan MJ, Risch HA, Rodríguez-Antona C, Rossing MA, Sandler DP, Setiawan VW, Shan K, Song H, Southey MC, Steed H, Sutphen R, Swerdlow AJ, Teo SH, Terry KL, Thompson PJ, Vestrheim Thomsen LC, Titus L, Trabert B, Travis R, Tworoger SS, Valen E, Van Nieuwenhuysen E, Edwards DV, Vierkant RA, Webb PM, OPAL Study Group, Weinberg CR, Weise RM, Wentzensen N, White E, Winham SJ, Wolk A, Woo YL, Wu AH, Yan L, Yannoukakos D, Zeinomar N, Zheng W, Ziogas A, Berchuck A, Goode EL, Huntsman DG, Pearce CL, Ramus SJ, Sellers TA, Ovarian Cancer Association Consortium (OCAC), Freedman ML, Lawrenson K, Schildkraut JM, Hazelett D, Plummer JT, Kar S, Jones MR, Pharoah PDP, Gayther SA
Enhancing anticancer activity of macrophages through rational drug combinations.
Mills GB, Labrie M
Remodeler le microenvironnement immunitaire du cancer ovarien à l'aide de virus oncolytiques
Principal investigators: Drouin, Zacharie
Keywords: Cancer Ovarien; Microenvironnement; Réponse Antitumorale; Traitement; Translationnel; Virus Oncolytiques
Colloque 'Signalisation Québec 2024'
Principal investigators: Jean, Steve
Keywords: Cancer; Cell Biology; Cell Signaling; Genetics; Immunology; Structure
Building of a functional single cell proteomics resource for the study the DNA damage response
Principal investigators: Labrie, Marilyne
Building of a functional single cell proteomics resource for the study the DNA damage response
Principal investigators: Labrie, Marilyne
Canada Research Chair - Tier 2
Principal investigators: Labrie, Marilyne
Keywords: Crc
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.